Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...
Insulin, used by millions of Americans, has taken center stage in the high-stakes battle over health care costs. Though ...
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...
UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.
The suit accuses the "Big Three" of steering diabetes patients toward high-priced insulin to benefit their bottom lines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback